» Articles » PMID: 38740827

XIST and MUC1-C Form an Auto-regulatory Pathway in Driving Cancer Progression

Overview
Journal Cell Death Dis
Date 2024 May 13
PMID 38740827
Authors
Affiliations
Soon will be listed here.
Abstract

The long non-coding RNA X-inactive specific transcript (lncRNA XIST) and MUC1 gene are dysregulated in chronic inflammation and cancer; however, there is no known interaction of their functions. The present studies demonstrate that MUC1-C regulates XIST lncRNA levels by suppressing the RBM15/B, WTAP and METTL3/14 components of the m6A methylation complex that associate with XIST A repeats. MUC1-C also suppresses the YTHDF2-CNOT1 deadenylase complex that recognizes m6A sites and contributes to XIST decay with increases in XIST stability and expression. In support of an auto-regulatory pathway, we show that XIST regulates MUC1-C expression by promoting NF-κB-mediated activation of the MUC1 gene. Of significance, MUC1-C and XIST regulate common genes associated with inflammation and stemness, including (i) miR-21 which is upregulated across pan-cancers, and (ii) TDP-43 which associates with the XIST E repeats. Our results further demonstrate that the MUC1-C/XIST pathway (i) is regulated by TDP-43, (ii) drives stemness-associated genes, and (iii) is necessary for self-renewal capacity. These findings indicate that the MUC1-C/XIST auto-regulatory axis is of importance in cancer progression.

Citing Articles

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

Dieli R, Lioy R, Crispo F, Cascelli N, Martinelli M, Lerose R Biomolecules. 2025; 15(2).

PMID: 40001578 PMC: 11853026. DOI: 10.3390/biom15020275.


Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy.

Cheng J, Sun M, Dong X, Yang Y, Qin X, Zhou X BMC Cancer. 2025; 25(1):161.

PMID: 39875895 PMC: 11773968. DOI: 10.1186/s12885-025-13560-y.


MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression.

Bhattacharya A, Wang K, Penailillo J, Chan C, Fushimi A, Yamashita N Oncogene. 2024; 43(28):2199-2214.

PMID: 38802648 PMC: 11226401. DOI: 10.1038/s41388-024-03068-3.

References
1.
Kufe D . Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. Int J Mol Sci. 2023; 24(4). PMC: 9967814. DOI: 10.3390/ijms24043719. View

2.
Ahmad R, Raina D, Trivedi V, Ren J, Rajabi H, Kharbanda S . MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling. Nat Cell Biol. 2007; 9(12):1419-27. PMC: 4209910. DOI: 10.1038/ncb1661. View

3.
Chen Y, Yen Y . The Ambivalent Role of lncRNA Xist in Carcinogenesis. Stem Cell Rev Rep. 2019; 15(2):314-323. DOI: 10.1007/s12015-019-9871-z. View

4.
Ke H, Zhao L, Zhang H, Feng X, Xu H, Hao J . Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3. Proc Natl Acad Sci U S A. 2018; 115(15):E3426-E3435. PMC: 5899436. DOI: 10.1073/pnas.1714573115. View

5.
Wang J, Lu A . The biological function of m6A reader YTHDF2 and its role in human disease. Cancer Cell Int. 2021; 21(1):109. PMC: 7885220. DOI: 10.1186/s12935-021-01807-0. View